Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 7Papillomavirus Infections 6Neoplasms 5Breast Neoplasms 4Uterine Cervical Dysplasia 3Melanoma 3Lung Neoplasms 3Herpes Zoster 3Condylomata Acuminata 3Vulvar Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Anus Neoplasms 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Vaginal Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Sarcoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Persistent Infection 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms, Glandular and Epithelial 1Nasopharyngeal Neoplasms 1

Interventions

Vaccines 3Mass Screening 1Herpes Zoster Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Herpes Zoster × Vaccines × Clear all
NCT01798056 2021-05-13

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy

GlaxoSmithKline

Phase 3 Completed
237 enrolled 20 charts

Herpes Zoster

NCT01254630 2019-09-30

V212-011

Merck Sharp & Dohme LLC

Phase 3 Completed
5,305 enrolled 20 charts
Other hematologic neoplasm

Herpes Zoster, Hematologic Neoplasms

NCT01460719 2019-03-11

V212-013

Merck Sharp & Dohme LLC

Phase 1 Completed
80 enrolled 13 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon âš¡